The pharmacoeconomic implications to costs versus adherence during clinical trials have been subject to numerous studies.  The effects are not only actual during clinical trials, but also once the drug is commercialized.  The quality of clinical trials results will depend on the quality of adherence data.  Therefore, scientists should use the best available technology to collect reliable dosing histories during clinical trials.

Among drugs granted Food and Drug Administration's approval between 1980 and 1999, 22% underwent significant post-marketing dose adjustments. 

Your scientists can count on DoseWatch technology.  Our solution consists of smart pharmaceutical packaging that monitors and reports patient medication adherence through instantaneous access to patient adherence history and drug disposal event.  Our smart pharmaceutical packaging can improve clinical trial efficiency and save time and money to your organization. 

DoseWatch Corporation puts in your hands smart pharmaceutical packaging along with a sophisticated software and a web-based data management tool to efficiently check for drug adherence among your enrolled patients.